Abbott India

{
  "main_header": {
    "sid": 919728,
    "name": "Abbott India",
    "stock_name": "Abbott India",
    "full_name": "Abbott India Ltd.",
    "name_url": "stocks-analysis/abbott-india",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "25,574.00",
    "chg": -500.5,
    "chgp": "-1.92%",
    "dir": -1,
    "prev_price": "26,074.50",
    "mcapval": "55,418.00 Cr",
    "mcap": "Mid Cap",
    "scripcode": 500488,
    "symbol": "ABBOTINDIA",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE358A01014",
    "curr_date": "Jun 23, 03:30 PM",
    "curr_time": "23:59 PM",
    "last_traded_at": "Jun 23, 03:30 PM IST",
    "bse_nse_vol": "27.1 k",
    "exc_status": "Active",
    "traded_date": "Jun 23, 2026",
    "traded_date_str": "2026 06 23",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/abbott-india-919728-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Abbott India Ltd. Technical Momentum Shifts Amid Mixed Indicator Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/abbott-india-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-4066638",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/AbbottIndiaLtd_technicaldot_4066638.png",
        "date": "2026-06-22 08:02:37",
        "description": "Abbott India Ltd., a mid-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a nuanced shift in its technical momentum, reflecting a complex interplay of bullish and bearish signals across key indicators. Despite a modest day gain of 0.32%, the stock’s technical parameters reveal a transition from bearish to mildly bearish trends, prompting a downgrade in its Mojo Grade from Hold to Sell as of 12 May 2026."
      },
      {
        "title": "Abbott India Ltd: 0.20% Dip Amid Bearish Technicals and Elevated Valuation Risks",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/abbott-india-ltd-020-dip-amid-bearish-technicals-and-elevated-valuation-risks-4065480",
        "imagepath": "",
        "date": "2026-06-20 14:03:36",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>15 Jun:</strong> Stock opens at ₹26,268.00, marginally down -0.02%</p>\n                    <p><strong>16 Jun:</strong> Decline continues to ₹26,089.00 (-0.68%) amid moderate volume</p>\n                    <p><strong>17 Jun:</strong> Further dip to ₹25,950.85 (-0.53%) despite Sensex gains</p>\n                    <p><strong>18 Jun:</strong> Recovery rally lifts stock to ₹26,136.20 (+0.71%)</p>\n                    <p><strong>19 Jun:</strong> Modest gain to ₹26,220.80 (+0.32%) but weekly close remains negative</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs...."
      },
      {
        "title": "Abbott India Ltd. Technical Momentum Shifts Amid Bearish Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/abbott-india-ltd-technical-momentum-shifts-amid-bearish-signals-4062651",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/AbbottIndiaLtd_technicaldot_4062651.png",
        "date": "2026-06-19 08:02:34",
        "description": "Abbott India Ltd., a mid-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, with key indicators signalling a transition from mildly bearish to bearish trends. Despite a modest day gain of 0.71%, the stock’s broader technical landscape suggests caution for investors as bearish signals intensify across multiple timeframes."
      },
      {
        "title": "Abbott India Ltd: Valuation Shifts Signal Heightened Price Risk Amidst Strong Fundamentals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/abbott-india-ltd-valuation-shifts-signal-heightened-price-risk-amidst-strong-fundamentals-4062576",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/AbbottIndiaLtd_valuationdot_4062576.png",
        "date": "2026-06-19 08:00:44",
        "description": "Abbott India Ltd., a prominent player in the Pharmaceuticals & Biotechnology sector, has seen its valuation metrics shift markedly, moving from expensive to very expensive territory. Despite a modest day gain of 0.71%, the stock’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios now stand well above peer averages, raising questions about price attractiveness amid mixed returns compared to the broader market."
      },
      {
        "title": "Abbott India Ltd. is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/abbott-india-ltd-is-rated-sell-4054033",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/AbbottIndiaLtd_mojoScore_4054033.png",
        "date": "2026-06-15 10:11:14",
        "description": "Abbott India Ltd. is rated Sell by MarketsMOJO, with this rating last updated on 12 May 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 15 June 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Abbott India Gains 0.98%: 2 Key Factors Driving the Week’s Mixed Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/abbott-india-gains-098-2-key-factors-driving-the-weeks-mixed-momentum-4051199",
        "imagepath": "",
        "date": "2026-06-13 11:07:18",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>8 June:</strong> Stock opens at Rs.25,792.95, declines 0.86%</p>\n                    <p><strong>9 June:</strong> Price rebounds 1.37% to Rs.26,145.70 amid improving technical signals</p>\n                    <p><strong>10 June:</strong> Technical momentum shifts amid mixed indicator signals; stock gains 1.27%</p>\n                    <p><strong>11 June:</strong> Price dips 1.53% to Rs.26,073.95 following cautious technical outlook</p>\n                    <p><strong>12 June:</strong> Valuation downgrade to Sell; stock recovers 0.76% to close at Rs.26,272.05</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-..."
      },
      {
        "title": "Abbott India Ltd: Valuation Shifts Signal Price Attractiveness Decline Amid Sector Comparison",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/abbott-india-ltd-valuation-shifts-signal-price-attractiveness-decline-amid-sector-comparison-4048213",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/AbbottIndiaLtd_valuationdot_4048213.png",
        "date": "2026-06-12 08:00:49",
        "description": "Abbott India Ltd., a prominent player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its valuation parameters, moving from a very expensive to an expensive rating. This change reflects evolving market perceptions and has implications for investors assessing the stock’s price attractiveness relative to its historical and peer benchmarks."
      },
      {
        "title": "Abbott India Ltd. Technical Momentum Shifts Amid Mixed Indicator Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/abbott-india-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-4043341",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/AbbottIndiaLtd_technicaldot_4043341.png",
        "date": "2026-06-10 08:05:06",
        "description": "Abbott India Ltd., a mid-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a nuanced shift in its technical momentum, reflecting a complex interplay of bullish and bearish signals across key indicators. Despite a recent upgrade from Hold to Sell by MarketsMOJO, the stock’s price action and technical parameters reveal a landscape of cautious optimism tempered by underlying weaknesses."
      },
      {
        "title": "Abbott India Ltd. is Rated Sell by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/abbott-india-ltd-is-rated-sell-by-marketsmojo-4035970",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/AbbottIndiaLtd_mojoScore_4035970.png",
        "date": "2026-06-04 10:10:20",
        "description": "Abbott India Ltd. is rated Sell by MarketsMOJO, with this rating last updated on 12 May 2026. While the rating change occurred on that date, the analysis and financial metrics discussed here reflect the stock’s current position as of 04 June 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      }
    ],
    "total": 251,
    "sid": "919728",
    "stock_news_url": "https://www.marketsmojo.com/news/abbott-india-919728"
  },
  "announcements": [
    {
      "caption": "Shareholder Meeting / Postal Ballot-Scrutinizers Report",
      "datetime": "17-Jun-2026",
      "details": "Scrutinizers Report on Postal Ballot.",
      "source": "BSE"
    },
    {
      "caption": "Communication To Shareholders - Intimation About Tax Deduction At Source On Dividend",
      "datetime": "15-Jun-2026",
      "details": "Communication to Shareholders - Intimation about Tax Deduction at Source on Dividend.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "03-Jun-2026",
      "details": "Newspaper Advertisement - Special Window for Transfer and Dematerialization of Physical Securities.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Abbott India Ltd. has declared <strong>5250%</strong> dividend, ex-date: 24 Jul 26",
          "dt": "2026-07-24",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Abbott India Ltd. Technical Momentum Shifts Amid Mixed Indicator Signals

2026-06-22 08:02:37

Abbott India Ltd., a mid-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a nuanced shift in its technical momentum, reflecting a complex interplay of bullish and bearish signals across key indicators. Despite a modest day gain of 0.32%, the stock’s technical parameters reveal a transition from bearish to mildly bearish trends, prompting a downgrade in its Mojo Grade from Hold to Sell as of 12 May 2026.

Read full news article

Abbott India Ltd: 0.20% Dip Amid Bearish Technicals and Elevated Valuation Risks

2026-06-20 14:03:36

Key Events This Week

15 Jun: Stock opens at ₹26,268.00, marginally down -0.02%

16 Jun: Decline continues to ₹26,089.00 (-0.68%) amid moderate volume

17 Jun: Further dip to ₹25,950.85 (-0.53%) despite Sensex gains

18 Jun: Recovery rally lifts stock to ₹26,136.20 (+0.71%)

19 Jun: Modest gain to ₹26,220.80 (+0.32%) but weekly close remains negative

Week Open

Rs....

Read full news article

Abbott India Ltd. Technical Momentum Shifts Amid Bearish Signals

2026-06-19 08:02:34

Abbott India Ltd., a mid-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, with key indicators signalling a transition from mildly bearish to bearish trends. Despite a modest day gain of 0.71%, the stock’s broader technical landscape suggests caution for investors as bearish signals intensify across multiple timeframes.

Read full news article

Abbott India Ltd: Valuation Shifts Signal Heightened Price Risk Amidst Strong Fundamentals

2026-06-19 08:00:44

Abbott India Ltd., a prominent player in the Pharmaceuticals & Biotechnology sector, has seen its valuation metrics shift markedly, moving from expensive to very expensive territory. Despite a modest day gain of 0.71%, the stock’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios now stand well above peer averages, raising questions about price attractiveness amid mixed returns compared to the broader market.

Read full news article

Abbott India Ltd. is Rated Sell

2026-06-15 10:11:14

Abbott India Ltd. is rated Sell by MarketsMOJO, with this rating last updated on 12 May 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 15 June 2026, providing investors with the latest insights into the company’s performance and outlook.

Read full news article

Abbott India Gains 0.98%: 2 Key Factors Driving the Week’s Mixed Momentum

2026-06-13 11:07:18

Key Events This Week

8 June: Stock opens at Rs.25,792.95, declines 0.86%

9 June: Price rebounds 1.37% to Rs.26,145.70 amid improving technical signals

10 June: Technical momentum shifts amid mixed indicator signals; stock gains 1.27%

11 June: Price dips 1.53% to Rs.26,073.95 following cautious technical outlook

12 June: Valuation downgrade to Sell; stock recovers 0.76% to close at Rs.26,272.05

Read full news article

Abbott India Ltd: Valuation Shifts Signal Price Attractiveness Decline Amid Sector Comparison

2026-06-12 08:00:49

Abbott India Ltd., a prominent player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its valuation parameters, moving from a very expensive to an expensive rating. This change reflects evolving market perceptions and has implications for investors assessing the stock’s price attractiveness relative to its historical and peer benchmarks.

Read full news article

Abbott India Ltd. Technical Momentum Shifts Amid Mixed Indicator Signals

2026-06-10 08:05:06

Abbott India Ltd., a mid-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a nuanced shift in its technical momentum, reflecting a complex interplay of bullish and bearish signals across key indicators. Despite a recent upgrade from Hold to Sell by MarketsMOJO, the stock’s price action and technical parameters reveal a landscape of cautious optimism tempered by underlying weaknesses.

Read full news article

Abbott India Ltd. is Rated Sell by MarketsMOJO

2026-06-04 10:10:20

Abbott India Ltd. is rated Sell by MarketsMOJO, with this rating last updated on 12 May 2026. While the rating change occurred on that date, the analysis and financial metrics discussed here reflect the stock’s current position as of 04 June 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

View All News